Envafolimab Combined With Axitinib as First-Line Treatment for Patients With Advanced Renal Cell Carcinoma
Clinical trial NCT07159191 · NOT_YET_RECRUITING
Trial details
- NCT number
- NCT07159191
- Sponsor
- Peking Union Medical College Hospital
- Status
- NOT_YET_RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2025-09-01
- Primary completion
- 2027-02-20
- Enrollment
- 30
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.